News Industry News Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada July 22, 2015
News Industry News Portola Pharmaceuticals Announces In Vivo Study Results Demonstrating Andexanet Alfa Significantly Reduced Bleeding and Reversed Anticoagulation Activity of Rivaroxaban While Four-Factor Prothrombin C June 25, 2015